Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.

Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.

Item
http://www.wikidata.org/entity/Q41613604
Understanding cachexia as a cancer metabolism syndromeThe Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established ConceptsProteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexia.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingNovel investigational drugs mimicking exercise for the treatment of cachexia.Metabolism and Skeletal Muscle Homeostasis in Lung Disease.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
P2860

Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.

Item
http://www.wikidata.org/entity/Q41613604
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.
@en
type
label
Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.
@en
prefLabel
Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932